Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Pharmacokinetics|November 30, 2011
Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug developmentKouichi Kurose, Emiko Sugiyama, Yoshiro Saito
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2015
[Predictive genomic markers for severe adverse drug reactions]Yoshiro Saito, Susumu Kodama, Emiko Sugiyama, et al.
Drug Metabolism and Pharmacokinetics|January 27, 2012
Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in JapaneseKeiko Maekawa, Jun Nishikawa, Nahoko Kaniwa, et al.
Journal of Molecular Graphics & Modelling|March 9, 2019
Structural significance of residues 158-160 in the H3N2 hemagglutnin globular head: A computational study with implications in viral evolution and infectionMarni E Cueno, Hayato Shiotsu, Karin Nakano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 23, 2009
Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjectsKeiko Maekawa, Noriko Harakawa, Emiko Sugiyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Identification of a predictive biomarker for hematologic toxicities of gemcitabineJunichi Matsubara, Masaya Ono, Ayako Negishi, et al.
Drug Metabolism and Pharmacokinetics|January 5, 2010
Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA geneEmiko Sugiyama, Su-Jun Lee, Sang Seop Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphismEmiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim, et al.
Molecular & Cellular Proteomics : MCP|January 12, 2010
Survival prediction for pancreatic cancer patients receiving gemcitabine treatmentJunichi Matsubara, Masaya Ono, Kazufumi Honda, et al.
Clinical Pharmacokinetics|July 9, 2010
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphismsEmiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim, et al.
Pageof 2